Dibutyryl Cyclophosphate Adenosine is commonly known as Dibutyryl Cyclophosphate Adenosine Calcium for Injection, and its effect is to activate protein kinase, and its function is to dilate the coronary artery, enhance the myocardial contractility, improve the myocardial hypoxia, and increase the volume of cardiac excretion, and so on. Calcium dibutyryl cyclophosphate adenosine for injection is a kind of protein kinase activator, with rapid onset of action and long-lasting effect, clinically used in the adjuvant treatment of acute myocardial infarction, angina pectoris, but also auxiliary to other anticancer drugs for the treatment of leukemia, as well as used in psoriasis, cardiogenic shock, myocarditis, and post-surgery submental hemorrhage. It should be noted that the use of Calcium Dibutyryl Cyclophosphate Adenosine for Injection is contraindicated in people who are allergic to any of the components of this drug. Adverse reactions such as nausea, vomiting, drowsiness, skin rash may occur when the drug is used in high dosage, and if the discomfort is severe, the doctor should be informed promptly so that appropriate treatment can be carried out. Calcium Dibutyryl Cyclophosphate for Injection should be used by a professional doctor, and patients should not use the drug on their own to avoid inducing side effects or affecting the condition.